Top Markets
Coin of the day
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Rang in Aktien #830
Zoetis Inc. stands as a global leader in animal health, focusing on the... Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
Aktienkurs
$71.40
Marktkapitalisierung
$29.93B
Veränderung (1 Tag)
-0.13%
Veränderung (1 Jahr)
-51.06%
Land
US
Handel Zoetis Inc. (ZTS)

Kategorie

Operative Marge für Zoetis Inc. (ZTS)
Operative Marge zum September 2026 TTM: 37.00%
Laut den neuesten Finanzberichten und dem Aktienkurs von Zoetis Inc. beträgt die aktuelle operative Marge (TTM) 37.00%. Am Ende des Jahres 2023 lag die operative Marge bei 35.92%.
Historie der operativen Marge von Zoetis Inc. von 2009 bis 2026
Operative Marge zum Jahresende
Jahr Operative Marge ändert
2026 (TTM) 37.00% 0.95%
2024 36.65% 2.03%
2023 35.92% -0.88%
2022 36.24% 0.53%
2021 36.05% 6.06%
2020 33.99% 5.43%
2019 32.24% -0.15%
2018 32.29% -0.77%
2017 32.54% 13.30%
2016 28.72% 26.46%
2015 22.71% 12.04%
2014 20.27% 12.61%
2013 18.00% -8.63%
2012 19.70% 21.91%
2011 16.16% 87.25%
2010 8.63% -15.23%
2009 10.18% 0.00%
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Operative Marge Differenz der operativen Marge Land
43.92% -98.81%
US
26.81% -99.28%
US
29.32% -99.21%
US
26.59% -99.28%
CH
16.65% -99.55%
US
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.